FMP

FMP

Enter

ACET - Adicet Bio, Inc.

Financial Summary of Adicet Bio, Inc.(ACET), Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell ther

photo-url-https://financialmodelingprep.com/image-stock/ACET.png

Adicet Bio, Inc.

ACET

NASDAQ

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.

1.37 USD

0.075 (5.49%)

About

ceo

Mr. Chen Schor BA, CPA, M.B.A.

sector

Healthcare

industry

Biotechnology

website

https://www.adicetbio.com

exchange

NASDAQ

Description

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is base...

CIK

0001720580

ISIN

US0070021086

CUSIP

007002108

Address

200 Clarendon Street

Phone

650 503 9095

Country

US

Employee

143

IPO Date

Jan 26, 2018

Summary

CIK

0001720580

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

007002108

ISIN

US0070021086

Country

US

Price

1.36

Beta

1.73

Volume Avg.

1.17M

Market Cap

112.17M

Shares

-

52-Week

1.1-5.0

DCF

3.22

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.46

P/B

-

Website

https://www.adicetbio.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest ACET News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep